We have characterized both the importance of intra and intermolecular Env dynamics in real viruses. Moreover, we have characterized these interactions in the presence of different ligands (such as the receptor sCD4 and different families of broadly neutralizing antibodies). Importantly, we have combined FLIM with single virus tracking when real HIV-1 viruses engaged with T cells demonstrating the importance of intermolecular dynamics and the establishment of Env functional clusters. This work was recently published (Carlon-Andres et al., 2021. Commun Biol)).
We have also investigated the importance of in innate immunity for HIV-1 entry. We have shown that the interferon-inducible transmembrane (IFITM) proteins have an antiviral function which is strictly related to their oligomeric state, and therefore both their potential to cluster and the mechanical tension in the membrane are crucial to understand their antiviral activity in the host. (Rahman et al., 2020. eLife).
In the context of HIV-1 transinfection we have put together a novel imaging approach able to render up to 9 different colours simultaneously. This has allowed to characterize HIV-1 cell-cell fusion and which are the molecular determinants for this process, including the role of Dynamin 2 and the stoichiometry of these interactions (Starling et al., 2022. BioRxiv/ Under review).
One of the caveats of this work was that we worked with an Env lab strain (termed HXB2). Currently, we have developed new labelling strategies employing nanobodies using a primary isolate (JR-FL) that presents different dynamics and is more resistant to bNabs neutralization. Importantly, we have employed artificial intelligence to evaluate the impact on the 3D structure of our labelling strategy and shown also with fusion and infection experiments that these labelled Envs are viable and functional. Our next step is to test these Env decorating HIV-1 viruses to understand their inter and intramolecular dynamics as compared with our previous results using the lab strain (HXB2).
Finally we have also presented our work in international conferences (CSH-Retroviruses, New York or EMBO 8th National Biosensor Meeting, France) both in 2022.